Benserazide is a peripherally acting aromatic L-amino acid decarboxylase inhibitor frequently administered in combination with levodopa to manage symptoms of Parkinson’s disease by preventing the peripheral… Read more























Benserazide is a peripherally acting aromatic L-amino acid decarboxylase inhibitor frequently administered in combination with levodopa to manage symptoms of Parkinson’s disease by preventing the peripheral conversion of levodopa to dopamine. This category provides a comprehensive selection of reference standards for Benserazide, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for critical analytical functions, such as impurity profiling, method validation, and routine quality control. By employing these characterized standards, researchers can effectively identify and quantify process-related impurities or degradation markers that may arise during formulation or storage. Additionally, the inclusion of stable isotope-labelled Benserazide supports precise quantification in complex analytical matrices, ensuring strict adherence to regulatory requirements and maintaining consistent product safety and therapeutic efficacy throughout the drug development lifecycle.